Severe community-acquired pneumonia (sCAP) is a major global health challenge, with high morbidity and mortality, especially ...

Objectives Infliximab, an anti-TNF agent, is used to treat sarcoidosis that does not respond to corticosteroids or second-line agents. The efficacy of other anti-TNF agents, non-TNF biologics and ...